NASDAQ (usa) |
![]() |
6715.56 | -12.11 | -0.18% |
FTSE 100 (london) |
![]() |
7487.96 | -5.12 | -0.07% |
DAX (german) |
![]() |
13465.51 | 235.94 | 1.78% |
NIKKEI 225 (japan) |
![]() |
22420.08 | 408.47 | 1.86% |
Hang - Seng (hong kong) |
![]() |
28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) |
![]() |
3391.61 | 17.53 | 0.52% |
KOSPI (korea) |
![]() |
2556.47 | 33.04 | 1.31% |
All Ordinaries (australia) |
![]() |
6005.30 | 28.90 | 0.48% |
BOVESPA (brazil) |
![]() |
74092.76 | -215.73 | -0.29% |
Ankur Drugs And Pharma Limited (NSE: ANKURDRUGS)
ANKURDRUGS Technical Analysis
1
As on N/A ANKURDRUGS SHARE Price closed @ N/A and we RECOMMEND N/A for LONG-TERM with Stoploss of N/A & N/A for SHORT-TERM with Stoploss of N/A we also expect STOCK to react on Following IMPORTANT LEVELS. |
ANKURDRUGSSHARE Price
Open | N/A | Change | Price | % |
High | N/A | 1 Day | N/A | N/A |
Low | N/A | 1 Week | N/A | N/A |
Close | N/A | 1 Month | N/A | N/A |
Volume | N/A | 1 Year | N/A | N/A |
52 Week High N/A | 52 Week Low N/A |
NSE INDIA Most Active Stocks
JPPOWER | 24.51 | -9.99% |
IDEA | 7.66 | -0.65% |
YESBANK | 20.46 | 2.35% |
RTNPOWER | 15.66 | -0.95% |
GTLINFRA | 1.71 | -0.58% |
SUZLON | 67.17 | 2.64% |
PCJEWELLER | 17.35 | 1.94% |
FILATFASH | 0.66 | -2.94% |
GATECH | 0.78 | -6.02% |
NMDC | 67.98 | -1.58% |
NSE INDIA Top Gainers Stocks
SUVIDHAA | 5.78 | 19.92% |
INDSWFTLTD | 18.91 | 14.81% |
JAYNECOIND | 48.50 | 13.53% |
AAATECH | 92.47 | 12.30% |
SWANENERGY | 502.25 | 11.38% |
DMCC | 297.70 | 10.69% |
AARTIDRUGS | 530.30 | 10.31% |
SWARAJENG | 4596.70 | 10.20% |
SAMPANN | 30.83 | 9.99% |
SOMATEX | 78.22 | 9.98% |
NSE INDIA Top Losers Stocks
ANKURDRUGS Daily Charts |
ANKURDRUGS Intraday Charts |
Whats New @ Bazaartrend |
ANKURDRUGS Free Analysis |
|
ANKURDRUGS Important Levels Intraday
RESISTANCE | |
RESISTANCE | |
RESISTANCE | |
RESISTANCE | |
RESISTANCE | |
RESISTANCE | |
RESISTANCE | |
RESISTANCE |
ANKURDRUGS Target July 2025
4th UP Target | |
3rd UP Target | |
2nd UP Target | |
1st UP Target | |
1st DOWN Target | |
2nd DOWN Target | |
3rd DOWN Target | |
4th DOWN Target |
ANKURDRUGS Weekly Target
4th UP Target | |
3rd UP Target | |
2nd UP Target | |
1st UP Target | |
1st DOWN Target | |
2nd DOWN Target | |
3rd DOWN Target | |
4th DOWN Target |
ANKURDRUGS Target2025
4th UP Target | |
3rd UP Target | |
2nd UP Target | |
1st UP Target | |
1st DOWN Target | |
2nd DOWN Target | |
3rd DOWN Target | |
4th DOWN Target |
Ankur Drugs And Pharma Limited ( NSE INDIA Symbol : ANKURDRUGS )
Sector : Pharmaceuticals - Formulations And Other Stocks in Same Sector
Sector : Pharmaceuticals - Formulations And Other Stocks in Same Sector
ANKURDRUGS Synopsis Technicals View
50 Day EMA |
N/A (Short Term) |
N/A | |
100 Day EMA | N/A (Mid Term) | N/A | |
200 Day EMA | N/A (Long Term) | N/A | |
MACD (12 26 9) | N/A | N/A | |
RSI (14) | N/A | N/A | |
MFI (14) | N/A | N/A | |
CCI (20) | N/A | N/A | |
WILLIAM %R (14) | N/A | N/A | |
ADX (14) | N/A | N/A | |
PSAR | N/A | N/A | |
10 Day Avg Volume | N/A |
ANKURDRUGS Other Details
Segment | BE | |
Market Capital | 0.00 | |
Sector | Pharmaceuticals - Formulations | |
Industry | ||
Offical website | > echo $website ; ?> |
ANKURDRUGS Address
![]() |
N/A |
ANKURDRUGS Latest News
ANKURDRUGS Business Profile
Ankur is extensively engaged in the manufacturing of pharmaceutical formulation since 1997, having multi location manufacturing units located at Daman [Union Territory] and Baddi [Himachal Pradesh].Ankur's first plant is situated at Daman, which is having dedicated block for General and Betalactum products in oral dosage form.
The Company has set-up two plants spread across "dimensions" at Himachal Pradesh in excise and pollution free zone, amongst lush green surroundings. The main object behind setting up two units was to cater Domestic and International Market.It has more than 400 different formulations of various dosage forms i.e. Tablets, Capsules, Dry Syrups, Liquid Orals, Injectables, Ointments, etc. are currently manufactured in Ankur's multi location manufacturing facilities.
The company has reported a standalone sales of Rs 36.12 crore and a Net Loss of Rs 40.84 crore for the quarter ended December 2012.
The Registered office is at C-306, Crystal Plaza, Andheri Link Road, Andheri(W), Mumbai,Maharashtra - 400053.
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service